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The DEVD motif of Crimean-Congo
hemorrhagic fever virus nucleoprotein
is essential for viral replication in tick cells
Cristiano Salata 1,2, Vanessa Monteil2,3, Helen Karlberg2,3, Michele Celestino1, Stephanie Devignot 4, Mikael Leijon5,
Lesley Bell-Sakyi6, Éric Bergeron7, Friedemann Weber 4 and Ali Mirazimi2,3,5
Dear Editor,
Crimean-Congo hemorrhagic fever (CCHF) is an
emerging tick-borne viral disease widely distributed
across countries of Africa, Southern Europe, the Middle
East, and Asia1. CCHF is caused by Crimean-Congo
hemorrhagic fever virus (CCHFV; genus Orthonairovirus,
family Nairoviridae), which usually circulates among
asymptomatic animals (mammals and ticks) in an
enzootic cycle. CCHFV has been detected in many tick
species, but Hyalomma spp. ticks represent the main viral
reservoir, and both transstadial and transovarial trans-
mission occur in this genus2. CCHFV causes severe dis-
ease in humans, with reported case fatality rates ranging
from ~5% to as high as 80% in different countries1. To
date, there is very limited knowledge available regarding
the biology and pathogenesis of CCHFV due to the
requirement for the virus to be handled in high-
containment laboratories1. In recent years, research pro-
grams have focused on understanding the virus-
mammalian host cell interaction to gain an overview of
the molecular pathogenesis of CCHFV3. Previously, we
demonstrated that there is an interplay between CCHFV
and the apoptosis process in mammalian cells4. Interest-
ingly, we found that the CCHFV nucleoprotein (N) con-
tains a proteolytic cleavage site, DEVD (a caspase-3
cleavage site), which is conserved in all CCHFV strains5.
Furthermore, we found that DEVD cleavage inhibits the
yield of progeny virus5. This ﬁnding raised the question of
why the DEVD motif has been conserved during evolution
of this RNA virus despite substantial genetic diversity
among CCHFV strains. This question might be answered
by studying the replication of CCHFV in its natural host:
ticks. The requirement for the virus to be handled in high-
containment laboratories, added to the difﬁculty in
manipulation of infected ticks in a biosafety level (BSL)-4
facility, has made this task challenging6,7. To shed light on
the role of the DEVD motif in CCHFV replication, we
have developed an in vitro tick cell culture model based
on a previous observation that tick cell lines can be
infected with CCHFV8. First, we characterized CCHFV
replication in the Hyalomma anatolicum-derived cell
lines HAE/CTVM8 and HAE/CTVM99 by evaluating viral
progeny release, the yield of intracellular viral RNA, and N
expression. HAE/CTVM8 and HAE/CTVM9 cells (2 ×
106) were seeded in sealed, ﬂat-sided culture tubes (Nunc,
Thermo Fisher Scientiﬁc) at 32 °C and grown for 48 h and
then infected with the CCHFV IbAr10200 strain10 at
multiplicities of infection (MOI) of 0.1 and 1.0, in 1 mL of
culture medium. After 1 h, cells were washed with PBS
and cultured in 2.5 mL of complete medium. In studies of
the kinetics of viral progeny release, 200 µL of supernatant
medium were collected, as indicated in Fig. 1a, for viral
titration on Vero cells, as previously described10, and an
equal volume of fresh medium was replaced in the culture
tubes.
Although both H. anatolicum cell lines were permissive
to CCHFV infection, the kinetics of viral replication dif-
fered between them. We found that CCHFV grew faster in
HAE/CTVM9 compared to HAE/CTVM8 at the early
time points; however, at later times post-infection (p.i.),
the yields of progeny virus were comparable between
these cells (Fig. 1a). At 7 days p.i., CCHFV-infected tick
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Fig. 1 (See legend on next page.)
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cells were sub-cultured, and viral infection was monitored
by viral titration or RT-PCR for 282 days p.i. Although the
sub-culturing of cells complicated the interpretation of
viral particle production (Fig. 1a), overall, our data indi-
cated the establishment of a persistent infection (Fig. 1a
and Supplementary Table 1).
To evaluate the intracellular viral RNA yield by quanti-
tative real-time Reverse Transcriptase-PCR (qRT-PCR),
CCHFV-infected cells were collected, washed with PBS
and lysed using the TRIzol LS reagent (Invitrogen). Total
RNA was extracted using a Direct-zol™ RNA MiniPrep
Kit (Zymo Research) and CCHFV RNA was detected
using a RealStar® CCHFV RT-PCR 1.0 kit (Altona Diag-
nostics) following the manufacturers’ instructions. The
amount of viral RNA was normalized to the expression
of the putative translation elongation factor EF-1 alpha/Tu
(EF1A) gene of H. anatolicum tick cells (primers available
on request) and expressed as the fold change with respect
to the initial virus inoculum (set to 1 at day 0, Fig. 1b)
using the ΔΔCt method for relative quantiﬁcation of
RNA11. The results showed that viral RNA increased
over time and was more abundant in HAE/CTVM9 cells
at the early time points (Fig. 1b). To evaluate viral protein
expression, cells were collected and washed in PBS by
centrifugation at 335 rcf for 7min at 4 °C and then
processed for western blotting analysis as previously
described4,5. The level of N protein expression was
MOI-dependent and was very high at MOI= 1.0 at 7 days
p.i. (Fig. 1c). In HAE/CTVM8 cells, the expression of
CCHFV-N was delayed in comparison to that in HAE/
CTVM9 cells (Fig. 1c).
Overall, our results showed that CCHFV replicated
faster in HAE/CTVM9 cells than in HAE/CTVM8 cells;
however, at day 7, the results were comparable between
the two cell lines.
These results could be due to the heterogeneity between
HAE/CTVM8 and HAE/CTVM9. In fact, all tick cell lines
are phenotypically and genotypically heterogeneous,
having been derived from the tissues of multiple embryos
of individual ticks, as reﬂected in their light microscopic
morphologic appearance8,9.
We then used our infection model to investigate the
importance of the DEVD motif for CCHFV replication in
tick cells. As highlighted above, we previously demon-
strated that the N protein can be cleaved in mammalian
cells by pro-apoptotic caspase-3 enzymes at the level of a
highly conserved DEVD motif, producing two polypep-
tides of approximately 30 and 26 kDa5,12. Using caspase
inhibitors, we found that cleavage of CCHFV-N affected
the yield of progeny virus and that N protein expression
could suppress the induction of apoptosis4. Thus, this
phenomenon could represent a host cell immune defense
mechanism against CCHFV infection5. Interestingly, we
could not detect such cleavage in tick cells, as western
blotting revealed a single ~50-kDa N protein (Fig. 1c). As
CCHFV persistently infected these cell lines, and con-
sidering the absence of detectable virus-induced cell
death, it is most likely that the virus efﬁciently inhibits
apoptosis in tick cells. However, we cannot exclude the
possibility that caspase-3 in these cells does not recognize
the DEVD site.
To further investigate the function of the DEVD motif
in CCHFV replication, we generated recombinant mutant
CCHFVs by the previously reported rescue system13,14.
The wild-type DEVD sequence (rCCHFVwt) was changed
to a caspase cleavage-resistant AEVA sequence
(rCCHFVmut) by site-directed mutagenesis. After two
steps of viral ampliﬁcation in SW13 cells (ATCC® CCL-
105™), the N protein coding sequences of the wild-type
and mutated recombinant viruses were veriﬁed by
nucleotide sequencing (data not shown). To evaluate the
ability of rCCHFVwt to replicate in tick cells, we com-
pared by qRT-PCR the kinetics of rCCHFVwt and parent
CCHFV IbAr10200 strain replication in HAE/CTVM8
cells, and the observed trends were similar (Fig. 1d). Then
human SW13 and tick HAE/CTVM8 cell lines were
infected with rCCHFVwt and rCCHFVmut at MOI 0.1.
Virus replication was evaluated by qRT-PCR of
(see ﬁgure on previous page)
Fig. 1 Replication of CCHFV in Hyalomma-derived tick cell lines. a–c Tick cell lines HAE/CTVM8 and HAE/CTVM9 were infected with CCHFV at
MOI 0.1 or MOI 1.0. At the indicated time points: a Infectious viral particles released were titrated by the focus forming unit (FFU) assay in Vero cells,
error bars= S.D.; b The relative increase in viral RNA in the infected cells was evaluated by qRT-PCR; c expression of the CCHFV-N protein was
evaluated by western blot, C= uninfected cells. The experiment was performed three times in duplicate, and sample analyses were performed in
duplicate. d HAE/CTVM8 cells were infected with the CCHFV IbAr10200 strain or rCCHFVwt at MOI 0.1. Viral replication was compared by measuring
the relative amount of viral RNA in the infected cells at the indicated time points. e–f Human SW13 and tick HAE/CTVM8 cells were infected with
rCCHFVwt or rCCHFVmut at MOI 0.1; viral replication was evaluated by: e titration of the virus progeny for both cell lines, and fmeasuring the relative
amount of viral RNA in the infected SW13 cells. *P < 0.05, unpaired t-test. The experiment was performed three times in duplicate, and sample
analyses were performed in duplicate. g HuH-7 (JCRB0403) donor cells were transfected with the CCHFV tc-VLP system, using either a wild-type
(pC_N) or a mutant (pC_N_D266+269A) N, in the context of a wild-type (L_wt) or a transcriptionally incompetent polymerase (L_D693A). An inactive
polymerase (L_ΔDD) was used as a control. Minigenome luciferase activity was measured 3 days post transfection. The presence of tc-VLPs in donor
cell supernatants was detected by transfer of supernatants onto HuH-7 indicator cells expressing L-wt and N and measurement of luciferase activity
24 h p.i. The results were normalized against the control L_wt+N_wt value set to 100%. The experiment was done in triplicate. h Replication of
rCCHFVwt and rCCHFVmut was also evaluated in HAE/CTVM8 cells over 17 days by measuring the relative amount of intracellular viral RNA.
*P < 0.002, ANOVA. The experiment was performed three times in duplicate, and sample analyses were performed in duplicate
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intracellular viral RNA and virus progeny titration. At 72
h, the titer of the rCCHFVmut in SW13 cells was
approximately ten times less than that of rCCHFVwt
(Fig. 1e), whereas intracellular rCCHFVmut RNA yield in
SW13 cells was 1.3 times greater than that of the wild type
(Fig. 1f). To investigate the DEVD motif-sensitive virus
replication step, we took advantage of our CCHF tran-
scriptionally competent virus-like particle (tc-VLP) sys-
tem developed in mammalian cells15 that allows
discrimination of the transcription and the replication
steps. As we already showed using a minireplicon system
in BSR-T7/5 cells12, we conﬁrmed using the tc-VLP sys-
tem in HuH-7 cells that mutation of the DEVD site
increases transcription. Indeed, in HuH-7 cells producing
VLPs (donor cells), transcription of the luciferase mini-
genome by the viral polymerase L_wt was increased in the
presence of the mutant (pC_N_D266+269A) N protein
(Fig. 1g). However, no major differences were found in
HuH-7 cells infected with VLPs (indicator cells), sug-
gesting the absence of an effect on replication or VLP
production. We also used a transcription-incompetent,
but replication-competent polymerase (L_D693A)15 and
similarly did not observe any major effects on replication/
VLP production. These data suggested that the DEVD
motif may have an as-yet undetermined function, but it is
not essential for virus replication in mammalian cells.
Strikingly, we found a strong-negative effect of the
AEVA mutation in HAE/CTVM8 cells. Although
rCCHFVwt was able to replicate in tick cells,
rCCHFVmut showed a strong impairment in RNA repli-
cation and only ~100 particles were detectable in just one
replicate in one of the experiments for rCCHFVmut
(Fig. 1e, h). The inability of rCCHFVmut to produce viral
progeny and the dramatic reduction in viral RNA (>99%
compared to RNA of the wild-type virus) (Fig. 1h) sug-
gested a signiﬁcant impairment of replication/transcrip-
tion of the viral genome that could be due to a
malfunction of the N protein in the tick intracellular
environment or the inability to interact with one or
more key cellular factors required for viral replication. To
date, there is a lack of molecular tools for tick cells, such
as mini replicon and VLP systems, such that we cannot
pinpoint the exact mechanism of function of the DEVD
motif. However, our data suggest that the DEVD
motif has an essential role in CCHFV replication in tick
cells.
In conclusion, our results support the applicability of
tick cell lines to studying the biology of CCHFV in vector
cells and virus/vector interactions. Processing of the
N protein appears to have a moderate effect on viral
replication in mammalian cells, but the dramatic inhibi-
tion of CCHFV replication after mutation of the DEVD
motif in tick cells raises an interesting question about the
function of this viral protein in the context of the vector.
Targeting the DEVD motif could be a strategy to coun-
teract infection in ticks to reduce viral persistence in the
environment. The virus/tick cell culture system reported
here provides the basis for further studies to characterize
the tick cellular response to CCHFV infections and to
determine the mechanism by which tick cells can tolerate
persistent viral infections.
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